August 14, 2026
If you've been dealing with a stubborn ankle sprain, a tendon injury that won't quite heal, or lingering plantar fasciitis pain that keeps interrupting your workouts, you may have come across a name circulating in recovery circles: BPC-157. Patients across Bethesda, McLean, and the greater DC metro area are increasingly asking their podiatrist about peptide therapy as a way to speed healing without surgery or extended downtime. At DD Podiatry, we've started incorporating peptide-based treatment into select recovery plans as part of our broader regenerative medicine approach, and patients want to know exactly what it is, how it works, and whether it's the right fit for their injury.
This guide walks through everything you need to know about using peptides for foot and ankle recovery — from the science behind them to what a treatment plan actually looks like at our Bethesda and McLean offices.
Peptides are short chains of amino acids — the same building blocks that make up the proteins in your body. Unlike full-sized proteins, peptides are small enough to trigger very specific cellular signals, which is why researchers have become so interested in using them for targeted tissue repair. The compound getting the most attention in foot and ankle care right now is BPC-157, sometimes called the "body protection compound." It's a synthetic peptide modeled after a naturally occurring protective compound found in the digestive tract, and early research suggests it may support new blood vessel formation, help regulate inflammation, and encourage the kind of tissue remodeling that's essential to healing tendons, ligaments, and other soft tissue.
In April 2026, the FDA revised its restricted compounding list for a group of peptides that includes BPC-157. That shift has opened the door for more clinics — including podiatry practices like ours — to responsibly offer this kind of treatment as part of a supervised recovery plan. It's still an evolving area of medicine, and we're upfront with every patient about what the current research does and doesn't show before recommending it. We view it as one more tool in a broader regenerative toolbox, not a miracle cure, and we only suggest it when the evidence and your individual case genuinely support it.
When you sprain an ankle, strain your Achilles tendon, or develop chronic plantar fasciitis, your body's natural healing response can stall out — especially in areas of the foot and ankle that have relatively limited blood flow to begin with. That's part of why tendon and ligament injuries in this part of the body are notorious for lingering far longer than a comparable soft tissue injury elsewhere, like a strained hamstring or a shoulder sprain.
Peptide-based treatment is thought to work by supporting the biological processes your body already uses to repair itself. That includes encouraging new blood vessel growth into damaged tissue (a process called angiogenesis), moderating the inflammatory signals that can either help or hinder healing depending on their intensity and timing, and supporting the fibroblast activity involved in rebuilding tendon and ligament fibers. At DD Podiatry, we typically pair this approach with other regenerative treatments — like PRP or exosome injections — when appropriate, using it either as an oral formulation or a localized injection to help accelerate the healing timeline for slow-to-heal injuries.
It's important to understand this isn't an instant fix. Tissue remodeling takes time regardless of what's supporting it biologically, and most patients think of this treatment as a way to shift the odds in their favor and shorten a recovery timeline that would otherwise drag on for months.
We most often recommend peptide therapy for Bethesda and McLean patients dealing with:
This treatment isn't the right fit for every patient or every diagnosis. Because this is still a developing field, we screen candidates carefully — reviewing your imaging, injury history, and overall health — before recommending it. Patients who are pregnant, have a history of certain cancers, or take medications with known interactions are typically not candidates. We'll walk through your full medical history during a consultation so you understand exactly why we are, or aren't, recommending it for your specific situation.
A typical consultation at our Bethesda or McLean office starts with a hands-on exam and, when needed, diagnostic imaging to confirm exactly what's driving your pain. From there, Dr. Tran or Dr. Niktash will discuss whether a peptide-based approach makes sense on its own or as part of a combination plan alongside shockwave therapy, PRP, or custom orthotics.
Depending on your injury, treatment may be delivered as an oral formulation or as a localized injection near the site of injury. Most patients tolerate it well, with no significant downtime — you can typically resume normal daily activities the same day you're treated. Full benefits build gradually rather than overnight, and most patients start noticing improvement within a few weeks, with continued healing over the following months as the underlying tissue remodels and strengthens.
Because this is a self-pay regenerative service — not something covered by traditional insurance — we go over cost and any applicable financing options clearly before you begin, so there are no surprises. We'll also set expectations for a realistic timeline based on your specific injury, since a six-week-old ankle sprain and a two-year-old Achilles problem heal on very different schedules.
Patients often ask how this compares to the other regenerative treatments we offer, like PRP injections, exosome therapy, or stem cell injections. The honest answer is that these treatments aren't competitors — they're tools that often work best in combination, tailored to the specific patient and injury.
During your consultation, we'll help you understand which combination — if any — gives you the best shot at a full, lasting recovery based on your specific diagnosis, activity level, and goals.
Dr. Nam Tran and Dr. Miriam Niktash bring board-certified surgical training and a deep focus on regenerative medicine to every patient conversation. We're not a medspa offering peptides as a general wellness add-on — we're podiatrists who evaluate your foot and ankle pain the way a specialist should, then determine whether this treatment or another regenerative option is genuinely appropriate for your diagnosis. That distinction matters: foot and ankle biomechanics are complex, and treatment decisions should be made by someone who understands the difference between a tendon issue, a ligament issue, and a joint issue at a structural level, not just a general practitioner offering peptides as a wellness trend.
Patients throughout Bethesda, McLean, and the wider DC metro and Northern Virginia region choose DD Podiatry because we combine that surgical-level expertise with a genuinely conservative, non-surgical-first philosophy. If a peptide-based approach isn't the right fit for your injury, we'll tell you plainly — and we'll walk you through what is, whether that's PRP, shockwave therapy, custom orthotics, or in some cases a referral for surgical evaluation.
If chronic foot or ankle pain has been slowing you down, it's worth finding out whether peptide therapy or another regenerative treatment could help you heal faster and get back to the activities you enjoy — whether that's running along the Capital Crescent Trail, keeping up with your kids, or simply walking pain-free again. Our team sees patients at two convenient locations: 6316 Democracy Blvd in Bethesda, MD, and 6849 Old Dominion Dr in McLean, VA.
Call (301) 363-2676 today to schedule a consultation and find out if peptide therapy is right for you. Same-week appointments are often available at both our Bethesda and McLean offices.